Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan
Autor: | Rodriguez Lanzi, Cecilia, Wei, Ran, Luo, Dingyuan, Mackenzie, Gerardo G. |
---|---|
Zdroj: | In Neoplasia February 2022 24(2):133-144 |
Databáze: | ScienceDirect |
Externí odkaz: |